Abstract: A mounting structure for mounting a frame garnish on a door window frame of a vehicle is disclosed. The door window frame includes a vertical portion extending in a generally vertical direction so as to overlap a center pillar of the vehicle. The door window frame is formed to surround a door window glass of the vehicle. The vertical portion includes a hooking hole formed in an upper part of the vertical portion and an insertion hole formed in a lower part of the vertical portion. The frame garnish includes a main portion, a hooking portion, and an insertion portion. The insertion portion is inserted into the insertion hole in the vertically downward direction, and the hooking portion is inserted into and hooked to the hooking hole.

Abstract: A mounting structure for mounting a frame garnish on a door window frame of a vehicle is disclosed. The door window frame includes a vertical portion extending in a generally vertical direction so as to overlap a center pillar of the vehicle. The door window frame is formed to surround a door window glass of the vehicle. The vertical portion includes a hooking hole formed in an upper part of the vertical portion and an insertion hole formed in a lower part of the vertical portion. The frame garnish includes a main portion, a hooking portion, and an insertion portion. The insertion portion is inserted into the insertion hole in the vertically downward direction, and the hooking portion is inserted into and hooked to the hooking hole.

Abstract: An object of the invention is to provide a substance that activates saccharide uptake in epidermal cells and is thus expected to be effective in promoting skin cell neogenesis and metabolism. The invention provides a promoter for saccharide uptake in epidermal keratinocytes which comprises a purine base or a salt thereof as an active ingredient. The present invention further provides a method of promoting saccharide uptake in epidermal keratinocytes, comprising applying a purine base or a salt thereof to the skin.

Abstract: A safe, economical, and convenient food drink having the effect of treating, preventing, or improving diabetes or diabetic complications without involving significantly changed dietary life habits is provided. A food or drink is provided for treating, preventing, or improving diabetes or diabetic complications, comprising oligosaccharides at a concentration of 0.15 to 10% by weight wherein the oligosaccarides include mannose molecules linked together with degree of polymerization of 2 to 10 (inclusive).

Abstract: An object of the invention is to provide a substance that activates saccharide uptake in epidermal cells and is thus expected to be effective in promoting skin cell neogenesis and metabolism. The invention provides a promoter for saccharide uptake in epidermal keratinocytes which comprises a purine base or a salt thereof as an active ingredient. The present invention further provides a method of promoting saccharide uptake in epidermal keratinocytes, comprising applying a purine base or a salt thereof to the skin.

Abstract: A lipolytic enzyme inhibitor is disclosed which comprises as an active ingredient at least one of a basic protein, a basic polypeptide and salt thereof. The inhibitor is useful as a dieting agent for the prevention of obesity and lipemia and as an additive for food and feed.

Abstract: A method of inhibiting enzymatic hydrolysis of lipids in a mammal concerns orally administering an effective amount of a purothionin or an .epsilon.-polylysine of the formula: ##STR1## or a salt thereof, wherein n is a number of from 5 to 9, to a mammal in need thereof. Alternatively, the method concerns orally administering an .epsilon.-polylysine of the formula above or a salt thereof, wherein n is a number of from 4 to 30, to a mammal suffering from lipemia or obesity. The purothionin, .epsilon.-polylysine or salt thereof is a lipolytic enzyme inhibitor, useful as a dieting agent, an agent for the prevention of obesity and lipemia, and as an additive for food and feed.

Abstract: An algin-containing food or beverage comprises a low-molecular weight algin which has a weight-average molecular weight in the range of 10,000-900,000 and still functions as a dietary fiber and has beneficial effects on the health. The algin can be prepared by subjecting a high-molecular weight naturally occurring algin or its derivative to heat treatment at a temperature of 100.degree.-200.degree. C. under pressure.

Abstract: An algin-containing food or beverage comprises a low-molecular weight algin which has a weight-average molecular weight in the range of 10,000-900,000 and still functions as a dietary fiber and has beneficial effects on the health. The algin can be prepared by subjecting a high-molecular weight naturally occurring algin or its derivative to heat treatment at a temperature of 100.degree.-200.degree. C. under pressure.

Abstract: A composition for reducing cancer symptoms by improving lipid metabolism and eliminating or reducing anorexia in tumor-bearing patients through inhibition of the lipid degradation-promoting action of toxohormone L which comprises an aqueous or aqueous organic solvent extract of one or more crude preparations selected from the group consisting of Astragali radix, Cinnamomi cortex, Rehmanniae radix, Paeoniae radix, Cnidii rhizoma, Atractylodis lanceae rhizoma, Angelicae radix, Ginseng radix, Hoelen and Glycyrrhizae radix, a method for preparing such a composition, and a method for reducing cancer symptoms using the composition.